Gardner syndrome in a Tunisian family: Identification of a rare APC mutation through targeted NGS

•Our study is the first genetic analysis of a Tunisian family with GS.•A rare APC pathogenic variant was identified in the GS patient by NGS.•Importance of genetic testing for early diagnosis and effective management. Gardner syndrome (GS) is a subtype of familial adenomatous polyposis (FAP) charact...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gene 2025-01, Vol.935, p.149065, Article 149065
Hauptverfasser: Abdelmaksoud-Dammak, Rania, Ammous-Boukhris, Nihel, Guidara, Souhir, Kamoun, Hassen, Gdoura, Hela, Barkia, Baha, Boudabbous, Mouna, Tahri, Nabil, Ameur, Hazem Ben, Boujelbene, Salah, Gargouri, Raja Mokdad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Our study is the first genetic analysis of a Tunisian family with GS.•A rare APC pathogenic variant was identified in the GS patient by NGS.•Importance of genetic testing for early diagnosis and effective management. Gardner syndrome (GS) is a subtype of familial adenomatous polyposis (FAP) characterized by colorectal polyps, multiple osteomas, soft tissue tumors, and specific oral manifestations, such as jaw osteomas. GS is caused by mutations in the APC gene, resulting in a nonfunctional protein. This study reports a comprehensive clinical evaluation and genetic analysis of a Tunisian family affected by GS. Targeted exome sequencing and Sanger sequencing techniques were employed to identify and validate mutations in the APC gene. Clinical observations of the patient revealed multiple sebaceous cysts, frontal and maxillary osteomas, and several gastrointestinal polyps. Genetic analysis revealed a pathogenic variant (c.4652-4655del) in the APC gene, leading to a truncated protein. Additionally, genetic testing of the patient’s child indicated that the child does not carry the APC pathogenic variant. In conclusion, our study highlights the importance of genetic testing in raising awareness of GS among clinicians to ensure early diagnosis and effective management, thereby reducing the risk of development and progression of colorectal cancer.
ISSN:0378-1119
1879-0038
1879-0038
DOI:10.1016/j.gene.2024.149065